Cargando…

A Mini Review of Novel Topoisomerase II Inhibitors as Future Anticancer Agents

Several reviews of inhibitors of topoisomerase II have been published, covering research before 2018. Therefore, this review is focused primarily on more recent publications with relevant points from the earlier literature. Topoisomerase II is an established target for anticancer drugs, which are fu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okoro, Cosmas O., Fatoki, Toluwase Hezekiah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916523/ https://www.ncbi.nlm.nih.gov/pubmed/36768852 http://dx.doi.org/10.3390/ijms24032532

Ejemplares similares

Human adenovirus DNA polymerase is evolutionarily and functionally associated with human telomerase reverse transcriptase based on in silico molecular characterization that implicate abacavir and zidovudine
por: Fatoki, Toluwase Hezekiah
Publicado: (2023)

In Silico Exploration of Metabolically Active Peptides as Potential Therapeutic Agents against Amyotrophic Lateral Sclerosis
por: Fatoki, Toluwase Hezekiah, et al.
Publicado: (2023)

Copper Complexes as Anticancer Agents Targeting Topoisomerases I and II
por: Molinaro, Caroline, et al.
Publicado: (2020)

Discovery of New Catalytic Topoisomerase II Inhibitors for Anticancer Therapeutics
por: Matias-Barrios, Victor M., et al.
Publicado: (2021)

Hybrid topoisomerase I and HDAC inhibitors as dual action anticancer agents
por: Cincinelli, Raffaella, et al.
Publicado: (2018)

In Silico Investigation of First-Pass Effect on Selected Small Molecule Excipients and Structural Dynamics of P-glycoprotein
por: Fatoki, Toluwase Hezekiah, et al.
Publicado: (2020)

Coronavirus Disease 2019 and Herbal Therapy: Pertinent Issues Relating to Toxicity and Standardization of Phytopharmaceuticals
por: Komolafe, Kayode, et al.
Publicado: (2021)

Natural Compounds as Anticancer Agents Targeting DNA Topoisomerases
por: Jain, Chetan Kumar, et al.
Publicado: (2017)

Design, synthesis, and biological evaluation of novel ciprofloxacin derivatives as potential anticancer agents targeting topoisomerase II enzyme
por: Swedan, Hadeer K., et al.
Publicado: (2022)

Secondary Leukemia Associated with the Anti-Cancer Agent, Etoposide, a Topoisomerase II Inhibitor
por: Ezoe, Sachiko
Publicado: (2012)

Design, Synthesis, and Anticancer Evaluation of Novel Indole Derivatives of Ursolic Acid as Potential Topoisomerase II Inhibitors
por: Li, A-Liang, et al.
Publicado: (2020)

Exploring DNA Topoisomerase I Ligand Space in Search of Novel Anticancer Agents
por: Drwal, Malgorzata N., et al.
Publicado: (2011)

Molecular docking analysis of α-Topoisomerase II with δ-Carboline derivatives as potential anticancer agents
por: Ayyamperumal, Selvaraj, et al.
Publicado: (2021)

Prospects of Topoisomerase Inhibitors as Promising Anti-Cancer Agents
por: Yakkala, Prasanna Anjaneyulu, et al.
Publicado: (2023)

A Unique Topoisomerase II Inhibitor with Dose-Affected Anticancer Mechanisms and Less Cardiotoxicity
por: Li, Zhi-Ying, et al.
Publicado: (2021)

An Improved High Yield Total Synthesis and Cytotoxicity Study of the Marine Alkaloid Neoamphimedine: An ATP-Competitive Inhibitor of Topoisomerase IIα and Potent Anticancer Agent
por: Li, Linfeng, et al.
Publicado: (2014)

DNA topoisomerases as molecular targets for anticancer drugs
por: Buzun, Kamila, et al.
Publicado: (2020)

Hyperthermia, thermotolerance and topoisomerase II inhibitors.
por: Kampinga, H. H.
Publicado: (1995)

The Implication of Topoisomerase II Inhibitors in Synthetic Lethality for Cancer Therapy
por: Matias-Barrios, Victor M., et al.
Publicado: (2023)

Voreloxin Is an Anticancer Quinolone Derivative that Intercalates DNA and Poisons Topoisomerase II
por: Hawtin, Rachael E., et al.
Publicado: (2010)

Mechanism of Generation of Therapy Related Leukemia in Response to Anti-Topoisomerase II Agents
por: Cowell, Ian G., et al.
Publicado: (2012)

DHFR Inhibitors: Reading the Past for Discovering Novel Anticancer Agents
por: Raimondi, Maria Valeria, et al.
Publicado: (2019)

Monofunctional Platinum(II) Anticancer Agents
por: Jin, Suxing, et al.
Publicado: (2021)

Design, synthesis, docking, and anticancer evaluations of new thiazolo[3,2-a] pyrimidines as topoisomerase II inhibitors
por: El-Zoghbi, Mona S., et al.
Publicado: (2023)

Secondary metabolites as DNA topoisomerase inhibitors: A new era towards designing of anticancer drugs
por: Baikar, Supriya, et al.
Publicado: (2010)

De novo design of type II topoisomerase inhibitors as potential antimicrobial agents targeting a novel binding region
por: Orritt, Kyle M., et al.
Publicado: (2022)

Mechanisms regulating resistance to inhibitors of topoisomerase II
por: Ganapathi, Ram N., et al.
Publicado: (2013)

On the structural basis and design guidelines for type II topoisomerase-targeting anticancer drugs
por: Wu, Chyuan-Chuan, et al.
Publicado: (2013)

In vitro anticancer screening of 24 locally used Nigerian medicinal plants
por: Fadeyi, Saudat Adamson, et al.
Publicado: (2013)

Antibacterial activity of novel dual bacterial DNA type II topoisomerase inhibitors
por: D’Atanasio, Noemi, et al.
Publicado: (2020)

The Structural Features of Novel Bacterial Topoisomerase Inhibitors That Define Their Activity on Topoisomerase IV
por: Kokot, Maja, et al.
Publicado: (2022)

Developments in Non-Intercalating Bacterial Topoisomerase Inhibitors: Allosteric and ATPase Inhibitors of DNA Gyrase and Topoisomerase IV
por: Grossman, Scott, et al.
Publicado: (2023)

Synthesis and Biological Evaluation of New Pyridothienopyrimidine Derivatives as Antibacterial Agents and Escherichia coli Topoisomerase II Inhibitors
por: Mohi El-Deen, Eman M., et al.
Publicado: (2020)

Relationship between expression of topoisomerase II isoforms and intrinsic sensitivity to topoisomerase II inhibitors in breast cancer cell lines.
por: Houlbrook, S., et al.
Publicado: (1995)

Relationship between expression of topoisomerase II isoforms and intrinsic sensitivity to topoisomerase II inhibitors in breast cancer cell lines
Publicado: (1996)

Investigating the potential anticancer activities of antibiotics as topoisomerase II inhibitors and DNA intercalators: in vitro, molecular docking, molecular dynamics, and SAR studies
por: Farouk, Faten, et al.
Publicado: (2023)

SGLT2 Inhibitors as Potential Anticancer Agents
por: Basak, Debasish, et al.
Publicado: (2023)

Investigating the Anticancer Potential of Salvicine as a Modulator of Topoisomerase II and ROS Signaling Cascade
por: Dey, Dipta, et al.
Publicado: (2022)

Antimicrobial Importance of Medicinal Plants in Nigeria
por: Ugboko, Harriet U., et al.
Publicado: (2020)

Identification of Novel 4′-O-Demethyl-epipodophyllotoxin Derivatives as Antitumor Agents Targeting Topoisomerase II
por: Xi, Wenli, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u6d2qjkm5r0ak4heddavoi9bci